Bicara Therapeutics Inc (BCAX)

NASDAQ · Biotechnology

23.29
+0.17 (+0.74%)
Updated Sep 1, 7:01 PM ET
AI Rating
Hold
Overall Score
42
Trend
61
Momentum
23
Risk
40

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Aug 18, 2025 260 sessions Aug 28, 2026

AI Analysis

Bicara Therapeutics Inc is trading at $23.29, up 0.74% on the session. The 50 day average sits at $26.60 and the 200 day at $20.80, which puts the stock in a uptrend. RSI is at 40.8, which reads as weak, and MACD is bearish crossover. Volume is below average.

The nearest support is around $22.94 with resistance near $26.95, so that band frames the current range. Average daily movement is roughly $1.48, or about 6.4% of the share price, which is what any stop placement has to allow for. The overall health score of 42 out of 100 combines a trend score of 61, momentum of 23 and a risk score of 40.

Technical indicators

RSI (14)
40.8
weak
MACD
-0.636
bearish crossover
SMA 20
25.12
SMA 50
26.60
SMA 200
20.80
uptrend
ATR (14)
1.48
avg daily range
Support
22.94
Resistance
26.95
Volume vs 20d
0.80x
below average
Volatility
77.2%
annualised
1 month
-10.81%
3 months
+7.72%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.